Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
1.770
+0.250 (16.45%)
At close: Jun 6, 2025, 4:00 PM
1.800
+0.030 (1.69%)
After-hours: Jun 6, 2025, 7:50 PM EDT

Marker Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-12.78-10.73-8.24-29.93-41.88-28.71
Upgrade
Depreciation & Amortization
----3.161.08
Upgrade
Stock-Based Compensation
0.550.250.863.35.965.23
Upgrade
Other Operating Activities
---5.81-0.28--0.03
Upgrade
Change in Accounts Receivable
-0.61-1.321.37-2.410.06
Upgrade
Change in Accounts Payable
0.140.01-0.72-1.324.143.05
Upgrade
Change in Unearned Revenue
----1.151.15-
Upgrade
Change in Other Net Operating Assets
0.130.892.190.1-0.82-0.7
Upgrade
Operating Cash Flow
-12.57-10.91-16.44-26.97-27.28-20.03
Upgrade
Capital Expenditures
-----3.13-9.25
Upgrade
Other Investing Activities
--18.66-4.95--
Upgrade
Investing Cash Flow
--18.66-4.95-3.13-9.25
Upgrade
Issuance of Common Stock
14.9414.991.110.252.566.74
Upgrade
Financing Cash Flow
14.9414.991.110.252.566.74
Upgrade
Net Cash Flow
2.374.083.33-31.7222.14-22.55
Upgrade
Free Cash Flow
-12.57-10.91-16.44-26.97-30.41-29.29
Upgrade
Free Cash Flow Margin
-220.73%-165.53%-496.51%-767.66%-2449.11%-6274.32%
Upgrade
Free Cash Flow Per Share
-1.32-1.22-1.87-3.23-3.98-6.23
Upgrade
Levered Free Cash Flow
-7.74-7.13-10.14-14.77-12.98-18.25
Upgrade
Unlevered Free Cash Flow
-7.74-7.13-10.14-14.77-12.98-18.25
Upgrade
Change in Net Working Capital
0.330.421.895.71-5.7-2.75
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q